Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 08 12 2020
revised: 25 12 2020
accepted: 28 12 2020
pubmed: 2 2 2021
medline: 24 6 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

This study aimed at estimating the SARS-CoV-2 infection hospitalization (IHR) and infection fatality ratios (IFR) in France. A serosurvey was conducted in 9782 subjects from the two French regions with the highest incidence of COVID-19 during the first wave of the pandemic and coupled with surveillance data. IHR and IFR were 2.7% and 0.49% overall. Both were higher in men and increased exponentially with age. The relative risks of hospitalization and death were 2.1 (95% CI: 1.9-2.3) and 3.8 (2.4-4.2) per 10-year increase, meaning that IHR and IFR approximately doubled every 10 and 5 years, respectively. They were dramatically high in the very elderly (80-90 years: IHR: 26%, IFR: 9.2%), and also substantial in younger adults (40-50 years: IHR: 0.98%, IFR: 0.042%). These findings support the need for comprehensive preventive measures to help reduce the spread of the virus, even in young or middle-aged adults.

Identifiants

pubmed: 33521775
doi: 10.1016/j.idnow.2020.12.007
pii: S2666-9919(20)00032-9
pmc: PMC7836556
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

380-382

Informations de copyright

© 2020 Elsevier Masson SAS. All rights reserved.

Références

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
J Clin Microbiol. 2021 Jan 21;59(2):
pubmed: 33139419
Epidemiology. 2013 Nov;24(6):830-41
pubmed: 24045719
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
Antiviral Res. 2020 Sep;181:104880
pubmed: 32679056

Auteurs

Nathanael Lapidus (N)

Sorbonne Université, Inserm, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Département de Santé Publique, Hôpital Saint-Antoine, APHP, Paris, France. Electronic address: nathanael.lapidus@inserm.fr.

Juliette Paireau (J)

Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France; Santé Publique France, French National Public Health Agency, Saint-Maurice, France.

Daniel Levy-Bruhl (D)

Santé Publique France, French National Public Health Agency, Saint-Maurice, France.

Xavier de Lamballerie (X)

Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, Inserm 1207, IHU Méditerranée Infection, 13005 Marseille, France.

Gianluca Severi (G)

Department of Statistics, Computer Science and Applications, University of Florence, Italy; CESP UMR1018, Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, Villejuif, France.

Mathilde Touvier (M)

Sorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Center-University of Paris (CRESS), Bobigny, France.

Marie Zins (M)

Paris University, Paris, France; Paris Saclay University, Inserm UMS 11, Villejuif, France.

Simon Cauchemez (S)

Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.

Fabrice Carrat (F)

Sorbonne Université, Inserm, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Département de Santé Publique, Hôpital Saint-Antoine, APHP, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH